NEW YORK, Jan 4 - Phylos, a privately held proteomics company that wants to develop the first high-throughput protein chip, announced Thursday that it had raised $25.1 million in a round of private financing.

The Lexington, Mass.-based company's principal investors include Three Arch Partners, Sprout Group, Lone Pine Capital, and Invemed Associates.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.